Cochlear Ltd
XMUN:OC5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cochlear Ltd
XMUN:OC5
|
AU |
|
Cavendish Hydrogen ASA
F:V07
|
NO |
|
L
|
Laboratory Corporation of America Holdings
F:LAB
|
US |
|
C
|
CENIT AG
XMUN:CSH
|
DE |
|
B
|
Basf Se
XHAM:BAS
|
DE |
Wall St Price Targets
OC5 Price Targets Summary
Cochlear Ltd
According to Wall Street analysts, the average 1-year price target for OC5 is 76.01 EUR with a low forecast of 37.04 EUR and a high forecast of 109.09 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OC5's stock price target?
Price Target
76.01
EUR
According to Wall Street analysts, the average 1-year price target for OC5 is 76.01 EUR with a low forecast of 37.04 EUR and a high forecast of 109.09 EUR.
What is the Revenue forecast for Cochlear Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Cochlear Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Cochlear Ltd?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 8 years is 6%.
What is the Pre-Tax Income forecast for Cochlear Ltd?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Cochlear Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 8 years is 3%.
